Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= VanLunen, B.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(6)
+
-
Availability
Open access
(2)
+
-
Metadata Only
(4)
+
-
Creation Date
2014
(2)
+
-
2017
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(6)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(6)
+
-
Author
Heijde, D. van der
(6)
+
-
VanLunen, B.
(6)
+
-
Vollenhoven, R. van
(6)
+
-
Bingham, C.O.
(3)
+
-
Burmester, G.R.
(3)
+
-
Bykerk, V.P.
(3)
+
-
Combe, B.
(3)
+
-
Emery, P.
(3)
+
-
Furst, D.E.
(3)
+
-
Keystone, E.
(3)
+
-
Landewe, R.
(3)
+
-
Mariette, X.
(3)
+
-
Shaughnessy, L.
(3)
+
-
Strand, V.
(3)
+
-
Weinblatt, M.E.
(3)
+
-
Arendt, C.
(2)
+
-
Mease, P.
(2)
+
-
Mountian, I.
(2)
+
-
Purcaru, O.
(2)
+
-
Tatla, D.
(2)
+
-
Show more
Language
en
(6)
+
-
Search results
(1 - 6 of 6)
show grid
show list
save search
Weinblatt, M.E.; Bingham, C.O.; Burmester, G.R.; Bykerk, V.P.; Furst, D.E.; Mariette, X.; ... ; Emery, P.
2017
A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis
Article / Letter to editor
open access
Emery, P.; Bingham, C.O.; Burmester, G.R.; Bykerk, V.P.; Furst, D.E.; Mariette, X.; ... ; Weinblatt, M.E.
2017
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naive patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study
Article / Letter to editor
open access
Emery, P.; Bingham, C.O.; Burmester, G.R.; Bykerk, V.P.; Furst, D.E.; Mariette, X.; ... ; Weinblatt, M.E.
2016
Response to: "Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers
Article / Letter to editor
metadata only
Keystone, E.; Landewe, R.; Vollenhoven, R. van; Combe, B.; Strand, V.; Mease, P.; ... ; Heijde, D. van der
2014
Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension
Article / Letter to editor
metadata only
Keystone, E.; Landewe, R.; Vollenhoven, R. van; Combe, B.; Strand, V.; Mease, P.; ... ; Heijde, D. van der
2014
Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 52-Week Randomized Controlled Trial and Open-Label Extension Study
Article / Letter to editor
metadata only
Keystone, E.; Landewe, R.; Vollenhoven, R. van; Combe, B.; Strand, V.; Mease, P.J.; ... ; Heijde, D. van der
2013
Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 52-Week Randomized Controlled Trial and Open-Label Extension Study
Article / Letter to editor
metadata only